Screener
TG Therapeutics TGTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $8.41B.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's market capitalization?
- TG Therapeutics (TGTX) reported market capitalization of $8.41B in Q2 2026.
- How has TG Therapeutics's market capitalization changed year-over-year?
- TG Therapeutics's market capitalization increased by 42.0% year-over-year, from $5.92B to $8.41B.
- What is the long-term trend for TG Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), TG Therapeutics's market capitalization has grown at a -8.6% compound annual growth rate (CAGR), from $7.44B to $4.73B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about TG Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude